Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

ClinicalTrials.gov ID: NCT06926842

Public ClinicalTrials.gov record NCT06926842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 9:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.

Study identification

NCT ID
NCT06926842
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zealand Pharma
Industry
Enrollment
221 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2025 (Actual)
Primary completion
Aug 13, 2026 (Actual)
Completion
Aug 13, 2026 (Actual)
Last update posted
Sep 9, 2026

2025 – 2026

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
Cullman Clinical Trials - Family Medicine Cullman Alabama 35055 —
AZ Endocrine Institute Chandler Arizona 85224 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
M3 Wake Research, Tucson Neuroscience Research, LLC Tucson Arizona 85710 —
Medical Investigation Inc Little Rock Arkansas 72211-1847 —
Velocity Clinical Research Huntington Park California 90255 —
Velocity Clinical Research, North Hollywood North Hollywood California 91606 —
Exalt Clinical Research San Diego California 91910 —
Diablo Clinical Research Inc. Walnut Creek California 94598 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Emerson Clinical Research Washington D.C. District of Columbia 20009 —
Innovative Research of West Florida Clearwater Florida 33756 —
East Coast Institute for Research, LLC Jacksonville Florida 32204 —
Solutions Through Advanced Research, Inc Jacksonville Florida 32216 —
M3 Wake Research - Lake City Lake City Florida 32055 —
West Orange Endocrinology P.A Ocoee Florida 34761 —
Palm Beach Research Center West Palm Beach Florida 33409 —
M3 Wake Research - Atlanta Atlanta Georgia 30328 —
East Coast Institute for Research - Canton Canton Georgia 30114 —
Privia Medical Group Georgia, LLC Savannah Georgia 31406 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Iowa Diabetes & Endocrinology Research Center West Des Moines Iowa 50266 —
Heartland Research Associates, LLC Wichita Kansas 67226 —
DelRicht Research - New Orleans New Orleans Louisiana 70115 —
AAMRC Flint Michigan 48504 —
International Diabetes Center Minneapolis Minnesota 55416 —
Velocity Clinical Research, Gulfport Gulfport Mississippi 39503 —
AMR Kansas City Kansas City Missouri 64114 —
Mercury Street Medical Group, PLLC Butte Montana 59701 —
M3 Wake Research - Las Vegas, NV Las Vegas Nevada 89106 —
Palm Research Center, Inc. Las Vegas Nevada 89148 —
Javara Inc Charlotte North Carolina 28210 —
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408 —
M3 Wake Research Raleigh North Carolina 27612 —
Velocity Clinical Research, Cincinnati, Mt. Auburn Cincinnati Ohio 45219 —
Centricity Research Columbus Ohio 43213 —
Lynn Institute of Norman Norman Oklahoma 73072 —
M3 Wake Research - Charleston Charleston South Carolina 29414 —
M3 Wake Research/ClinSearch, LLC Chattanooga Tennessee 37421 —
Elligo Clinical Research, Inc. Austin Texas 78704 —
The University of Texas Southwestern Medical Center Dallas Texas 75390-8857 —
Juno Research LLC Houston Texas 77040 —
Tekton Research, LLC Irving Texas 75039 —
Tekton Research, LLC McKinney Texas 75069 —
Texas Health Care, PLLC San Marcos Texas 78666 —
Consano Clinical Research Shavano Park Texas 78231 —
Texas Health Care Stephenville Texas 76401 —
Manaasas Clinical Research Center Manassas Virginia 20110 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06926842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06926842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →